Cancer Pathology and Prevention Faculty

Chair, Cancer Pathology and Prevention
Kirsten Moysich, PhD
Distinguished Professor of Oncology
Department of Cancer Prevention and Control
Department of Immunology
Email: Kirsten.Moysich@roswellpark.org

Director of Graduate Studies, Cancer Pathology and Prevention
Richard J. O’Connor, PhD
Professor of Oncology
Department of Health Behavior
Email: Richard.O'Connor@RoswellPark.org

Faculty Member Research Interest

Christine Ambrosone, PhD, Senior Vice President, Population Sciences; Chair, Department of Cancer Prevention and Control

Molecular epidemiology of cancer risk; breast cancer in African-American women; cancer treatment outcomes
AnneMarie W. Block, PhD, Laboratory Director, Cytogenetics Laboratory Chromosome abnormalities in B-cell lymphoproliferative; mitogenic stimulation of human B cells; fluorescence in situ hybridization (FISH)
Paul Bogner, MD, Assistant Professor of Oncology Department of Pathology and Laboratory Medicine Thoracic oncology, including the histological and molecular diagnosis, classification and staging of lung tumors, neoplastic and inflammatory dermatopathology
Richard T. Cheney, MD, Chair, Department of Pathology and Laboratory Medicine Photodynamic Therapy, cutaneous mast cells, dermatopathology

Deborah O. Erwin, PhD, Director, Office of Cancer Health Disparities Research

Development and testing of community-based interventions to address social determinants of inequities in cancer detection, treatment and access among minority and medically underserved populations.
Barbara Foster*, PhD, Associate Professor of Oncology, Department of Pharmacology and Experimental Therapeutics Vitamin D analogs, selenium, dendritic cell vaccine, mechanisms of prostate cancer development
Theresa Hahn, PhD Professor of Oncology, Department of Medicine Clinical epidemiology, outcomes research, evidence-based medicine; blood and marrow transplantation; and infectious disease epidemiology
Chi-Chen Hong, PhD, Associate Professor of Oncology, Department of Cancer Prevention and Control The role of lifestyle-related factors on hormonal exposures and immune function in breast cancer survivors, impact of type 2 diabetes on cancer prognosis, thermal dysregulation among breast cancer patients  
Assistant Professor of Oncology, Department of Cancer Pathology and Prevention
Medical Psychologist, Department of Psychosocial Oncology
Adjustment to breast cancer, survivorship, evaluation of the efficacy of palliative care treatment in alleviating physical and psychosocial symptoms
 
Andrew Hyland, PhD, Chair, Department of Health Behavior Evaluating the impact of policies aimed at reducing the morbidity and mortality associated with the use of tobacco products
Surabhi Kakati, PhD, Assistant Research Director, Cytogenetics Laboratory chromosomal abnormalities in leukemias, lymphomas and solid tumors

Sue Leong, PhD, Emeritus Faculty, Department of Pathology and Laboratory Medicine

New drug development, clinical trials, medical ethics, continuing medical education and immunology
Martin Mahoney, MD, PhD, Director, Cancer Prevention & Detection Center, Employee Health Clinic; Professor, Department of Cancer Prevention and Control Cancer screening utilization and promotion; effect of Chernobyl-related radiation exposure on the risk of leukemia; smoking cessation
James R. Marshall, PhD, Distinguished Professor Emeritus Selenium for chemoprevention, biomarkers to measure chemoprevention and molecular epidemiology
Patricia A. Masso-Welch, PhD, Adjunct Assistant Professor, Department of Cancer Prevention and Control The impact of lifestyle interventions during developmental time points of rapid mammary gland remodeling (e.g., during puberty, post-lactational involution) on breast cancer risk and progression 
Susan McCann, PhD, Professor of Oncology, Department of Cancer Prevention and Control Nutritional and molecular epidemiology including the impact of diet on cancers of the reproductive organs
Philip McCarthy, MD, Professor of Oncology and Chief, Division of Blood and Marrow Transplantation, Department of Medicine Health effects of radiation exposure, modulation of graft versus host disease and of chemotherapy toxicity, blood and marrow stem cell isolation, immune modulation after transplantation
Kirsten Moysich, PhD, Distinguished Professor of Oncology, Department of Cancer Prevention and Control Ovarian cancer etiology and prognosis, immunosuppression, novel immune markers
Associate Professor of Oncology, Department of Cancer Prevention and Control
Associate Professor of Surgery, Department of Thoracic Surgery
Lung cancer lymph node metastasis, disparities in lung cancer care, cancer control in resource-limited environments
Richard O’Connor, PhD, Professor of Oncology, Department of Health Behavior  Tobacco product regulation; tobacco harm reduction; development of unobtrusive and minimally invasive measures of tobacco exposure in humans
Roberto Pili, MD, Professor of Oncology, Chief of Genitourinary section, Department of Medicine Drug development for genitourinary malignancies: combination strategies with chromath remodeling agents, antiangiogenics and immunotherapies
Mary Reid, PhD, Distinguished Professor of Oncology, Department of Medicine Early detection and chemoprevention of lung and head and neck cancers; Biomarkers of exposure and risk for aerodigestive cancer
Laura Rusche, PhD, Assistant Professor, Department of Biological Sciences, University at Buffalo  
Sheila N. J. Sait, PhD, Research Director, Cytogenetics Laboratory Double minute chromosomes (dms) and homogeneously staining regions (hsr) in leukemia and MDS
Gary J. Smith, PhD, Co-Leader, Prostate Program, Distinguished Professor, Oncology, Department of Urologic Oncology Prevention and treatment of prostate cancer; prostatic stem cells, angiogenesis; racial differences in prostate cancer mortality.
Li Tang, PhD, Associate Professor of Oncology, Department of Cancer Prevention and Control Molecular epidemiology, nutritional epidemiology and dietary intervention, chemoprevention, cancer survivorship
Maansi Bansal-Travers, PhD, Assistant Professor of Oncology, Department of Health Behavior

Risk perceptions of tobacco and nicotine products;  tobacco marketing, point-of-sale advertising, and counter marketing; tobacco packaging characteristics and health warning labels

Mark J. Travers, PhD, Assistant Professor of Oncology, Department of Health Behavior and Aerosol Pollution Exposure Research Laboratory (APERL).

Tobacco smoke pollution exposure; evaluation of smokefree air and other tobacco control policies; new and emerging tobacco products.

Paul K. Wallace, PhD, Director of Flow Cytometry Laboratory Flow cytometry, immunotherapy of cancer
Yue Wu, PhD, Assistant Professor of Oncology, Department of Urology

Cancer prevention, cancer therapy, biology of prostate cancer

Song Yao, PhD, Associate Professor of Oncology,
Department of Cancer Prevention and Control
Biological factors and related genetic variations in breast cancer etiology
Yuesheng Zhang, PhD, Professor of Oncology and Member, Department of Cancer Prevention and Control Chemoprevention of bladder cancer, drug development in cancer prevention

*Joint Appointment